Register for a live webcast-"A New CD38-Directed Antibody for the Treatment of Appropriate Relapsed Refractory Multiple Myeloma Patients"

General Discussions

Improving Care for Patients With Metastatic Breast Cancer

By Panelists: Joyce OShaughnessy, MD; Michael Reff, RPh, MBA; Sara M. Tolaney, MD, MPH; Lindsay Shaw, NP; Kate Jeffers, PharmD
General Discussions - Discussions
9 replies


Transcript: 

Sara M. Tolaney, MD, MPH: Adherence is such a challenge because I think many of us don’t even realize that all our patients aren’t really taking all the medications we prescribe. Even when we would just give hormonal therapy by itself, about 25% of patients weren’t even taking the medication. And so it’s striking. And I think you’re never going to know unless you ask. But I think Lindsay and I have made it a point with all our visits to not only ask what adverse effects are they experiencing, but are they actually taking their drug, and how many times did they miss taking their drug, and why did they miss taking their drug?

You know sometimes it’s because of an adverse effect and they really just can’t bear the thought of taking a drug that’s causing them adverse effects. Sometimes it’s financial reasons. You know sometimes the copayment is just too high and they didn’t pick up their last prescription. But, again, you’re not going to know unless you ask. And so we’ve made it part of the routine visit. “How many times have you missed taking your drugs this past month,” or whatever it’s been. We do this just so we get a sense of what’s going on and then see if we can fix it. We work to find out what the reason is so that we can help with their drug.

Lindsay Shaw, NP: I feel anecdotally though with these drugs that it seems less likely to occur than with other drugs. With people taking their supportive medications, they’re often very erratic with that. But this is a new level beyond just endocrine therapy for them and they feel that they really need to take it because they’re worried about their cancer having recently progressed. So I hear less about adherence with these than some other drugs that they’ve been prescribed.

There’s a team at our institute that is required to call patients who start any oral antineoplastic agents. So that’s built in. And usually the program nurses that we have are in touch with them anyway about procuring the drugs. So, if anything, I sometimes get reports that they’re having too many phone calls. But, yes, it’s rare that they’re not hearing from 1 or more people.

Sara M. Tolaney, MD, MPH: I think the class of CDK4/6 [cyclin-dependent kinases 4 and 6] inhibitors has really revolutionized the way we treat patients with metastatic hormone receptor-positive disease. I think it’s unique that these agents are able to control disease for twice as long as endocrine therapy would have, and now we see a survival benefit in the second-line setting. Generally they’re pretty well tolerated agents that allow patients to get oral drugs. They’re not coming into clinic as much as they would be with IV [intravenous] chemotherapies. And yet, they’re also able to cause significant objective responses. You know we typically think of endocrine therapy as not causing significant reduction in tumor volume, but that isn’t the case with CDK4/6 inhibitors added to endocrine treatment where the first-line response rate is as high as 50%.

And so, I think it also allows us to see patients in clinic, and even though they may have significant visceral involvement, we’re able to give them endocrine therapy with a CDK4/6 inhibitor. Whereas 10 years ago, these are patients that would have been getting chemotherapy in the first-line setting. So it’s completely changed the way we practice. And, again, it’s so hopeful to see that it’s also improving their long-term outcomes. So I really do feel like it is standard of care to give a CDK4/6 inhibitor with endocrine therapy, whether it be in the first- or second-line setting.

Lindsay Shaw, NP: It’s amazing that they have an opportunity to take something oral that we see such wonderful responses to. A lot of these patients are coming off of having maybe progressed on endocrine therapy and they’re not facing having to do IV chemotherapy. And I always tell people that this is something that’s doable. You can live your life pretty normally while you’re taking this. And that, in the end, is what everybody that has metastatic breast cancer wants to do. They want to just keep living their life as they were, and this really lets them do that.

Transcript Edited for Clarity 
By sunnyydv12
Mar 01, 2020 2:49:16 am
By milan
Mar 04, 2020 12:11:34 am
Accidentally i have come across this website and here we can see the engagement and wedding band set news regarding the cancer patient. We can see the details regarding how to improve care for patients with metastatic breast cancer. I am looking for more updates from here.
By adamhebrew
Mar 05, 2020 6:34:30 am
Such a nice blog post on this topic. We acknowledge how essential it is for you to submit perfectly crafted assignments. This is why we ensure to offer our professional nursing essay help, whenever you find the process of writing the essays too intimidating.
By Stephen
Mar 09, 2020 3:23:02 am
Thank you, you have made some good information provide I really enjoyed this stuff I appreciate your content. nursing essay writing service
By Leah Johnson
Mar 10, 2020 2:40:41 am
Nursing students always look for the Best Nursing Writing Services since its very difficult to complete Custom Nursing Research Papers and Nursing Assignment Writing Services on time.
By jenniechase
Mar 13, 2020 6:41:56 am
Breast cancer is such a pathetic disease these days my maternal aunt is suffering from this. It's really painful to see her like this, the doctor suggested us the surgery and on the other side he is saying we can track this with medicine currently we are working with the medicines, medicines are very costly for me being a student it's not easy to buy so I use Online coupon codes and that help me to get the products with some massive discounts.
By burkkevin
Mar 19, 2020 2:23:37 am
Fabulous posting! A lot of important details and points. Poe Dameron Jacket
By romandavis
Mar 24, 2020 10:43:23 am
I have heard all the conversations about the patient. I think you are doing a general discussion on this topic but you have to get some steps to complete it. Masters dissertation writing service
By najwayaminah
Mar 24, 2020 12:50:56 pm
Breast Cancer is spreading all over the world and due to this thousand of cases are registered in every country. We need to figure this out by spreading Essay Writing Service in UAE information and awareness about this disease because without this we can over this terrifying disease.
Reply
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.